Status:
ACTIVE_NOT_RECRUITING
Norwegian Laparoscopic Aortic Surgery Trial
Lead Sponsor:
Oslo University Hospital
Conditions:
Aortobifemoral Bypass
Aortoiliac Occlusive Disease
Eligibility:
All Genders
Phase:
NA
Brief Summary
Patients with severe atherosclerotic occlusive disease can be operated on with an aortobifemoral bypass(ABFB)through a median laparotomy. Since 1993, this operation has also been performed laparoscopi...
Detailed Description
The primary endpoint of the study is post-operative complications defined as systemic and local complications, including vascular complications e.g., graft infection, thrombosis, etc. Secondary endpo...
Eligibility Criteria
Inclusion
- Aortoiliac occlusive disease (TASC Type D lesions)
Exclusion
- Active cancer disease
- Acute critical limb ischemia
- Prior major abdominal surgery
- Heart failure (Ejection fraction \<40%
Key Trial Info
Start Date :
February 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2026
Estimated Enrollment :
126 Patients enrolled
Trial Details
Trial ID
NCT01793662
Start Date
February 1 2013
End Date
December 30 2026
Last Update
July 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of vascular surgery, Oslo University Hospital
Oslo, Norway